$THMO
ThermoGenesis Holdings, Inc.

2020 Q1 Form 10-K Financial Statement

#000143774920005945 Filed on March 24, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019
Revenue $3.200M $1.720M $13.05M
YoY Change 8.04% -36.06% 34.89%
Cost Of Revenue $1.708M $1.130M $7.351M
YoY Change 0.23% -39.57% -1.71%
Gross Profit $1.492M $590.0K $5.696M
YoY Change 18.6% -28.05% 159.74%
Gross Profit Margin 46.63% 34.3% 43.66%
Selling, General & Admin $2.092M $3.190M $8.033M
YoY Change 30.67% 36.32% -16.71%
% of Gross Profit 140.21% 540.68% 141.03%
Research & Development $609.0K $640.0K $2.396M
YoY Change 8.17% 42.22% -20.45%
% of Gross Profit 40.82% 108.47% 42.06%
Depreciation & Amortization $199.0K $210.0K $805.0K
YoY Change -3.4% 31.25% 20.15%
% of Gross Profit 13.34% 35.59% 14.13%
Operating Expenses $2.701M $3.830M $10.43M
YoY Change 24.82% 37.28% -77.2%
Operating Profit -$1.209M -$3.240M -$4.733M
YoY Change 33.44% 64.47% -89.13%
Interest Expense $3.531M -$960.0K $4.479M
YoY Change 211.93% 26.32% 66.07%
% of Operating Profit
Other Income/Expense, Net -$3.000K -$10.00K -$33.00K
YoY Change -66.67% -125.0% 37.5%
Pretax Income -$4.740M -$4.200M -$10.10M
YoY Change 131.22% -50.99% -77.89%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.743M -$4.050M -$10.10M
YoY Change 131.7% -43.44% -75.33%
Net Earnings / Revenue -148.22% -235.47% -77.4%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.111M -$1.286M -$3.357M
COMMON SHARES
Basic Shares Outstanding 4.561M 2.844M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.720M $3.160M $3.160M
YoY Change 155.36% 31.67% 31.67%
Cash & Equivalents $5.719M $3.157M $3.160M
Short-Term Investments
Other Short-Term Assets $1.430M $1.600M $1.600M
YoY Change 361.29% 627.27% 627.27%
Inventory $4.218M $3.484M $3.820M
Prepaid Expenses
Receivables $2.029M $1.278M $1.280M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.40M $9.521M $9.860M
YoY Change 51.3% 10.38% 14.25%
LONG-TERM ASSETS
Property, Plant & Equipment $1.904M $2.028M $2.890M
YoY Change -22.06% -20.84% 12.89%
Goodwill $781.0K $781.0K
YoY Change 0.0% 0.0%
Intangibles $1.434M $1.467M
YoY Change -8.14% -7.79%
Long-Term Investments $10.00K
YoY Change
Other Assets $61.00K $218.0K $210.0K
YoY Change 19.61% 327.45% -80.0%
Total Long-Term Assets $5.009M $5.693M $5.350M
YoY Change -26.09% -4.88% -10.54%
TOTAL ASSETS
Total Short-Term Assets $13.40M $9.521M $9.860M
Total Long-Term Assets $5.009M $5.693M $5.350M
Total Assets $18.40M $15.21M $15.21M
YoY Change 17.75% 4.13% 4.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.457M $1.447M $1.450M
YoY Change -0.28% -40.28% -40.08%
Accrued Expenses $850.0K $2.160M $2.160M
YoY Change -8.6% -2.7% -2.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.481M $6.685M $6.690M
YoY Change 15.59% 5.03% 5.02%
LONG-TERM LIABILITIES
Long-Term Debt $4.760M $4.930M $4.930M
YoY Change 85.94% 321.37% 321.37%
Other Long-Term Liabilities $19.00K $20.00K $2.680M
YoY Change -94.22% -47.37% 688.24%
Total Long-Term Liabilities $19.00K $20.00K $7.610M
YoY Change -94.22% -47.37% 403.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.481M $6.685M $6.690M
Total Long-Term Liabilities $19.00K $20.00K $7.610M
Total Liabilities $13.80M $14.30M $14.83M
YoY Change 47.57% 81.45% 140.36%
SHAREHOLDERS EQUITY
Retained Earnings -$241.5M -$236.9M
YoY Change 5.33% 4.18%
Common Stock $6.000K $3.000K
YoY Change -72.73% 50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.216M $386.0K $390.0K
YoY Change
Total Liabilities & Shareholders Equity $18.40M $15.21M $15.21M
YoY Change 17.75% 4.13% 4.11%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$4.743M -$4.050M -$10.10M
YoY Change 131.7% -43.44% -75.33%
Depreciation, Depletion And Amortization $199.0K $210.0K $805.0K
YoY Change -3.4% 31.25% 20.15%
Cash From Operating Activities -$2.541M $260.0K -$3.260M
YoY Change 4.31% -42.22% -53.32%
INVESTING ACTIVITIES
Capital Expenditures $23.00K $0.00 $182.0K
YoY Change -39.47% -100.0% -85.3%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$23.00K $0.00 -$182.0K
YoY Change -39.47% -100.0% -85.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.133M 100.0K 4.199M
YoY Change 122.11% -600.0% -40.95%
NET CHANGE
Cash From Operating Activities -2.541M 260.0K -3.260M
Cash From Investing Activities -23.00K 0.000 -182.0K
Cash From Financing Activities 5.133M 100.0K 4.199M
Net Change In Cash 2.562M 360.0K 757.0K
YoY Change -1671.78% 100.0% -168.01%
FREE CASH FLOW
Cash From Operating Activities -$2.541M $260.0K -$3.260M
Capital Expenditures $23.00K $0.00 $182.0K
Free Cash Flow -$2.564M $260.0K -$3.442M
YoY Change 3.64% -62.86% -58.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000811212
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4561017
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
4733000
CY2019 dei Entity Registrant Name
EntityRegistrantName
ThermoGenesis Holdings, Inc.
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Security12b Title
Security12bTitle
Common Stock, $.001 par value
CY2019 dei Trading Symbol
TradingSymbol
thmo
CY2019 thmo Adjustments To Additional Paid In Capital Exercise Of Prefunded Warrants
AdjustmentsToAdditionalPaidInCapitalExerciseOfPrefundedWarrants
42000
CY2019 thmo Intangible Assets Net Excluding Goodwill Amortization And Foreign Currency Translation Gain Loss
IntangibleAssetsNetExcludingGoodwillAmortizationAndForeignCurrencyTranslationGainLoss
124000
CY2019Q4 thmo Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
1869000
CY2018Q4 thmo Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
1513000
CY2019 thmo Inventory Change In Reserve
InventoryChangeInReserve
92000
CY2018 thmo Inventory Change In Reserve
InventoryChangeInReserve
-11000
CY2019 thmo Maximum Period Of Agreement
MaximumPeriodOfAgreement
P21Y
CY2019Q4 thmo Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1646214
CY2018Q4 thmo Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1656668
CY2019Q4 thmo Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights
22.91
CY2018Q4 thmo Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights
27.80
CY2019 thmo Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
435264
CY2018 thmo Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
269167
CY2019 thmo Class Of Warrant Or Right Exercised During Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodWeightedAverageExercisePrice
0.35
CY2018 thmo Class Of Warrant Or Right Exercised During Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodWeightedAverageExercisePrice
0.10
CY2019 thmo Class Of Warrant Or Right Expired Or Cancelled During Period
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
19637
CY2018 thmo Class Of Warrant Or Right Expired Or Cancelled During Period
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
CY2019 thmo Class Of Warrant Or Right Expired Or Cancelled During Period Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodWeightedAverageExercisePrice
CY2018 thmo Class Of Warrant Or Right Expired Or Cancelled During Period Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodWeightedAverageExercisePrice
CY2019 thmo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
444445
CY2018 thmo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
1512816
CY2019 thmo Class Of Warrant Or Right Issued During Period Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodWeightedAverageExercisePrice
0.10
CY2018 thmo Class Of Warrant Or Right Issued During Period Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodWeightedAverageExercisePrice
4.20
CY2018Q4 thmo Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
29.88
CY2017Q4 thmo Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
93.70
CY2019Q4 thmo Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
25.23
CY2018 thmo Cumulative Effects Of New Accounting Principle In Period Of Adoption
CumulativeEffectsOfNewAccountingPrincipleInPeriodOfAdoption
-79000
CY2019Q4 thmo Deferred Tax Assets Lease Obligation
DeferredTaxAssetsLeaseObligation
185000
CY2018Q4 thmo Deferred Tax Assets Lease Obligation
DeferredTaxAssetsLeaseObligation
CY2019Q4 thmo Deferred Tax Liabilities Lease Asset
DeferredTaxLiabilitiesLeaseAsset
180000
CY2018Q4 thmo Deferred Tax Liabilities Lease Asset
DeferredTaxLiabilitiesLeaseAsset
CY2019 thmo Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount
EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount
1119000
CY2018 thmo Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount
EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount
240000
CY2019 thmo Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount
EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount
1187000
CY2018 thmo Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount
EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount
1271000
CY2019 thmo Effective Income Tax Rate Reconciliation Intangible Assets Amount
EffectiveIncomeTaxRateReconciliationIntangibleAssetsAmount
673000
CY2018 thmo Effective Income Tax Rate Reconciliation Intangible Assets Amount
EffectiveIncomeTaxRateReconciliationIntangibleAssetsAmount
3119000
CY2019 thmo Fair Value Of Amended Convertible Note Issued
FairValueOfAmendedConvertibleNoteIssued
1473000
CY2018 thmo Fair Value Of Amended Convertible Note Issued
FairValueOfAmendedConvertibleNoteIssued
CY2019 thmo Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities
IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities
1492000
CY2018 thmo Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities
IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities
2000
CY2018 thmo Intangible Assets Net Excluding Goodwill Amortization And Foreign Currency Translation Gain Loss
IntangibleAssetsNetExcludingGoodwillAmortizationAndForeignCurrencyTranslationGainLoss
152000
CY2019 thmo Nonoperating Income Expense Including Interest Expense
NonoperatingIncomeExpenseIncludingInterestExpense
-5366000
CY2018 thmo Nonoperating Income Expense Including Interest Expense
NonoperatingIncomeExpenseIncludingInterestExpense
-2125000
CY2019 thmo Operating Lease Interest Expense
OperatingLeaseInterestExpense
204000
CY2019 thmo Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
108000
CY2017Q2 thmo Payment Terms Severance Compensation
PaymentTermsSeveranceCompensation
P1Y
CY2018Q1 thmo Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
1213000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6869441
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
CY2019 thmo Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
756000
CY2018 thmo Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
6629000
CY2018Q2 thmo Proceeds From Issuance Or Sale Of Equity Net
ProceedsFromIssuanceOrSaleOfEquityNet
4792000
CY2019 thmo Recording Of Beneficial Conversion Feature On Debt
RecordingOfBeneficialConversionFeatureOnDebt
2313000
CY2018 thmo Recording Of Beneficial Conversion Feature On Debt
RecordingOfBeneficialConversionFeatureOnDebt
7200000
CY2019 thmo Reorganization Of Subsidiary And Related Change In Noncontrolling Interest
ReorganizationOfSubsidiaryAndRelatedChangeInNoncontrollingInterest
CY2018Q4 thmo Sharebased Compensation Arrangements By Sharebased Payment Award Options Subject To Approval Of Amendment Plan
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsSubjectToApprovalOfAmendmentPlan
169934
CY2017Q2 thmo Short Term Investment Minimum
ShortTermInvestmentMinimum
2000000
CY2018 thmo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
27000
CY2019 thmo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
112000
CY2019 thmo Transfer Of Equipment To Inventories
TransferOfEquipmentToInventories
44000
CY2018 thmo Transfer Of Equipment To Inventories
TransferOfEquipmentToInventories
172000
CY2019 thmo Transfer Of Inventories To Equipment
TransferOfInventoriesToEquipment
22000
CY2018 thmo Transfer Of Inventories To Equipment
TransferOfInventoriesToEquipment
420000
CY2018Q2 thmo Units Issued Price Per Unit
UnitsIssuedPricePerUnit
6
CY2019Q4 thmo Working Capital
WorkingCapital
3176000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1447000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2423000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1278000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1509000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5898000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5433000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
237313000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
235888000
CY2018 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
7200000
CY2019 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
2313000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
652000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
614000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
614000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
652000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
226000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
419000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2349000
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1174000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
124000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
131000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8367074
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
33081000
CY2019Q4 us-gaap Assets
Assets
15214000
CY2018Q4 us-gaap Assets
Assets
14611000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
9861000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
8626000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3157000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2400000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3400000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4513000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4157000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
757000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1113000
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1726522
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
482873
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1716066
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2843601
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2168337
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2843601
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2168337
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9482000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39686000
CY2019 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-602000
CY2018 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1224000
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10084000
CY2018 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-40910000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Credit Risk</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Currently, the Company primarily manufactures and sells cellular processing systems and thermodynamic devices principally to the blood and cellular component processing industry and performs ongoing evaluations of the credit worthiness of the Company&#x2019;s customers. The Company believes that adequate provisions for uncollectible accounts have been made in the accompanying consolidated financial statements. To date, the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced significant credit related losses.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2019Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
413000
CY2018Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7351000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7479000
CY2019 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
432000
CY2018 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
46000
CY2018Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4730000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
588000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
419000
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
1049000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
620000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
485000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1901000
CY2018Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
303000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
419000
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
CY2019Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
384000
CY2018Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
850000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31446000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31958000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26758000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27312000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
943000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1027000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2757000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2769000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30858000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31539000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
408000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
419000
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2018 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2019 us-gaap Depreciation
Depreciation
574000
CY2017Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
597000
CY2018 us-gaap Depreciation
Depreciation
539000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
805000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
670000
CY2019 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1000
CY2018 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
596000
CY2018Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1000
CY2019Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
CY2019Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
3518000
CY2018Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
1174000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.36
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-21.57
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
CY2018 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
288000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
703000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
24000
CY2018 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
45000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
993000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
891000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
79000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
109000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
32000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
32000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
32000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
40000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1317000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1355000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
448000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
324000
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-70000
CY2018 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1360000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-840000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6377000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8286000
CY2017Q4 us-gaap Goodwill
Goodwill
13976000
CY2018Q4 us-gaap Goodwill
Goodwill
781000
CY2019Q4 us-gaap Goodwill
Goodwill
781000
CY2018 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
13195000
CY2019 us-gaap Gross Profit
GrossProfit
5696000
CY2018 us-gaap Gross Profit
GrossProfit
2193000
CY2018 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
19886000
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
16000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9934000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-45458000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10099000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45670000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-150000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-212000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-15000
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2019Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4730000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-681000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2084000
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2118000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9591000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
25000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-29000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-205000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2344000
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-966000
CY2018 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
214000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-301000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1045000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
135000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
24000
CY2019 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
355000
CY2018 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-606000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-415000
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
172000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-610000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-61000
CY2019 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1143000
CY2018 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
922000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
525000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-370000
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2460000
CY2018Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22368000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21629000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1591000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1467000
CY2019 us-gaap Interest Expense
InterestExpense
4479000
CY2018 us-gaap Interest Expense
InterestExpense
2697000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
177000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
667000
CY2019Q4 us-gaap Inventory Net
InventoryNet
3824000
CY2018Q4 us-gaap Inventory Net
InventoryNet
4493000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
258000
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
350000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1397000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
301000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
139000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
328000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
319000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
310000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
538000
CY2019Q4 us-gaap Liabilities
Liabilities
14298000
CY2018Q4 us-gaap Liabilities
Liabilities
7880000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15214000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14611000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6685000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6365000
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1000000
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
CY2019Q4 us-gaap Minority Interest
MinorityInterest
530000
CY2018Q4 us-gaap Minority Interest
MinorityInterest
-1711000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4199000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7111000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-182000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1238000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3260000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6983000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-602000
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1224000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9497000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-39716000
CY2018 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-40940000
CY2019 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-10099000
CY2019 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2019 us-gaap Operating Expenses
OperatingExpenses
10429000
CY2018 us-gaap Operating Expenses
OperatingExpenses
45738000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-4733000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-43545000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
410000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
859000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
761000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
291000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
859000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.22
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y146D
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
218000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
51000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15000
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
30000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2461000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1241000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
38000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-33000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000
CY2018Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
679000
CY2018Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
171000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
182000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1238000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
602000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
224000
CY2019 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Reclassifications</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have an impact on net loss as previously reported.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2019 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1800000
CY2018 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2018Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5473000
CY2019 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1513000
CY2018 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
500000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
154000
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
27000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
186000
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1000000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-236932000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-227435000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2396000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3012000
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
291000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
277000
CY2019 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
154000
CY2018 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
252000
CY2019 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-9000
CY2018 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-52000
CY2019 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
254000
CY2018 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
199000
CY2019 us-gaap Profit Loss
ProfitLoss
-10099000
CY2018 us-gaap Profit Loss
ProfitLoss
-40940000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7926000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7995000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2028000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2562000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-60000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
153000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
1000000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12160000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9003000
CY2019 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
887000
CY2018 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
669000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1148000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
932000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
528000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
390000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
971000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3969000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2019Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2019Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2019Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2019Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2019 us-gaap Revenues
Revenues
13047000
CY2018 us-gaap Revenues
Revenues
9672000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
966000
CY2018 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6629000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
756000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
386000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8442000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1656000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1359000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
614000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
652000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.03
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.03
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0168
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.027
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
147124
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
19.79
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
22011
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
800000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
214000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11450
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.30
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.20
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
280000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
302368
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
291807
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.99
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.96
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
203000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
224102
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
15.72
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.42
CY2019Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.65
CY2018Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.979
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.38
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
115000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y328D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y109D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y73D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
428000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
633000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
300000
CY2018Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
22.70
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
26000
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
60964
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
432000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
33212000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6731000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
916000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, the allowance for doubtful accounts, carrying amounts of inventories, depreciation and amortization, warranty obligations, assumptions made in valuing financial instruments issued in various compensation and financing arrangements, deferred income taxes and related valuation allowance and the fair values of intangibles and goodwill. Actual results could materially differ from the estimates and assumptions used in the preparation of the Company&#x2019;s consolidated financial statements.</div></div></div></div></div></div></div>
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-681000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2266000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
72000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2828606
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1841281

Files In Submission

Name View Source Status
0001437749-20-005945-index-headers.html Edgar Link pending
0001437749-20-005945-index.html Edgar Link pending
0001437749-20-005945.txt Edgar Link pending
0001437749-20-005945-xbrl.zip Edgar Link pending
ex_176867.htm Edgar Link pending
ex_176868.htm Edgar Link pending
ex_176869.htm Edgar Link pending
ex_176870.htm Edgar Link pending
ex_178317.htm Edgar Link pending
ex_178318.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thmo-20191231.xml Edgar Link completed
thmo-20191231.xsd Edgar Link pending
thmo-20191231_cal.xml Edgar Link unprocessable
thmo-20191231_def.xml Edgar Link unprocessable
thmo-20191231_lab.xml Edgar Link unprocessable
thmo-20191231_pre.xml Edgar Link unprocessable
thmo20191231_10k.htm Edgar Link pending
thmo20191231_10kimg001.jpg Edgar Link pending